Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations

Human Vaccines

Volumn 5, Issue 5, 2009, Pages 341-346

  Launay, Odile ^a,b,c   Toneatti, Christine ^d   Bernède, Claire ^d   Njamkepo, Elisabeth ^d   Petitprez, Karine ^b,c   Leblond, Annie ^e   Larnaudie, Sylvie ^f   Goujon, Catherine ^d   Ungeheuer, Marie Noelle ^d   Ajana, Faïza ^g   Raccurt, Christian ^h   Beytout, Jean ⁱ   Chidiac, Christian ^j   Bouhour, Damien ^k   Guillemot, Didier ^d,l,m   Guiso, Nicole ^d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Pôle de Médecine ^*  (France)

^c INSERM   (France)

^d INSTITUT PASTEUR   (France)

^e Centro de Médecine Preventive   (France)

^f DASES   (France)

^g Tourcoing Hospital   (France)

^h AMIENS UNIVERSITY HOSPITAL   (France)

ⁱ HÔTEL DIEU   (France)

^j CROIX ROUSSE HOSPITAL   (France)

^k Service des Maladies Infectieuses et Tropicales Hôpital de Fleyriat   (France)

^l LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^m INSERM U657   (France)

more..

Author keywords

Boosters; Diphtheria; Pertussis; Tetanus; Vaccination

Indexed keywords

BACTERIUM ANTIBODY; DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS ANTIBODY; TETANUS ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; DIPHTHERIA; FEMALE; FRANCE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNOSURVEILLANCE; MALE; NORMAL HUMAN; PERTUSSIS; SEROEPIDEMIOLOGY; TETANUS; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, BACTERIAL; DIPHTHERIA; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; FRANCE; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; TETANUS; WHOOPING COUGH; YOUNG ADULT;

EID: 70349521831     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.5.5.7575     Document Type: Article

References (17)

1. Anonymous. Calendrier vaccinal 2008 - Avis du Haut conseil de la santé publique. Bull Epidemiol Heb 2008; 17:1-20.
2. Beytout J, Denis F, Giet R, Allaert FA. Regional variations of adult population vaccinal status. Med Mal Infect 2004; 34:460-8.
3. Guthman JP, Fonteneau L, Antona D, Levy-Bruhl D. La couverture vaccinale diphtérie, tétanos, poliomyélite chez l'adulte en France: Résultats de l'enquête Santé et Protection Sociale, 2002. Bull Epidemiol Heb 2007; 52:441-5.
4. Antona D. Le tétanos en France en 2002-2004. Bull Epidemiol Heb 2006; 7:53-9.
5. Lartigue MF, Monnet X, Le Fleche A, Grimont PA, Benet JJ, Durrbach A, et al. Corynebacterium ulcerans in an immunocompromised patient with diphtheria and her dog. J Clin Microbiol 2005; 43:999-1001.
6. Tiwari TS, Golaz A, Yu DT, Ehresmann KR, Jones TF, Hill HE, et al. Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis 2008; 46:395-401.
7. Galaska A, Tomadzunas-Blaszczyck J. Why do adults contract diphtheria? Euro Surveill 2000; 2:60-3.
8. World Health Organization. Update: Diphtheria epidemic in the newly independent states of the former URSS January 1995-March 1996. Weekly Epidemiological Record 1996; 71:245-50.
9. Grimprel E, Guiso N, Bégué P. New aspects of pertussis in France, 26 years after generalized pertussis vaccination. Biologicals 1993; 21:5-6.
10. Baron S, Njamkepo E, Grimprel E, Begue P, Desenclos JC, Drucker J, et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: Thirty years after a routine use of vaccination. Pediat Inf Dis J 1998; 17:412-8.
11. Gilberg S, Njamkepo E, Du Chatelet IP, Partouche H, Gueirard P, Ghasarossian C, et al. Evidence of Bordetella pertussis Infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002; 186:415-8.
12. Wendelboe AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol 2007; 4:15.
13. Simondon F, Iteman I, Preziosi MP, Yam A, Guiso N. Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal. Clin Diagn Lab Immunol 1998; 5:130-4.
14. Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA, et al. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect 2000; 125:113-25.
15. Hainz U, Jenewein B, Asch E, Pfeiffer KP, Berger P, Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 2005; 23:3232-5.
16. McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 2002; 136:660-6.
17. Bonmarin I, Levy-Bruhl D, Baron S, Guiso N, Njamkepo E, Caro V. Pertussis surveillance in French hospitals: Results from a 10 year period. Euro Surveill 2007; 12:(http://www.eurosurveillance.org/em/ v12n01/1201-226.asp.).